Covenant Partners’s Merck MRK Stock Holding History

Covenant Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-11,758	Closed	-$1.34M	–	170
2024 Q3	$1.34M	Buy	11,758 +236	+2%	+$28K	0.39%	33
2024 Q2	$1.43M	Hold	11,522	–	–	0.43%	27
2024 Q1	$1.52M	Hold	11,522	–	–	0.44%	26
2023 Q4	$1.26M	Hold	11,522	–	–	0.4%	33
2023 Q3	$1.19M	Hold	11,522	–	–	0.43%	30
2023 Q2	$1.33M	Hold	11,522	–	–	0.48%	24
2023 Q1	$1.23M	Hold	11,522	–	–	0.47%	30
2022 Q4	$1.28M	Hold	11,522	–	–	0.51%	25
2022 Q3	$992K	Sell	11,522 -432	-4%	-$38.6K	0.48%	32
2022 Q2	$1.09M	Hold	11,954	–	–	0.5%	32
2022 Q1	$981K	Buy	11,954 +432	+4%	+$34.1K	0.39%	44
2021 Q4	$883K	Hold	11,522	–	–	0.33%	64
2021 Q3	$865K	Hold	11,522	–	–	0.34%	61
2021 Q2	$896K	Sell	11,522 -2,970	-20%	-$221K	0.34%	57
2021 Q1	$1.07M	Sell	14,492 -2,849	-16%	-$210K	0.42%	43
2020 Q4	$1.35M	Buy	17,341 +1,918	+12%	+$147K	0.57%	28
2020 Q3	$1.22M	Buy	15,423 +525	+4%	+$41.1K	0.59%	24
2020 Q2	$1.1M	Hold	14,898	–	–	0.51%	33
2020 Q1	$1.09M	Sell	14,898 -1,309	-8%	-$103K	0.58%	25
2019 Q4	$1.41M	Hold	16,207	–	–	0.66%	23
2019 Q3	$1.3M	Hold	16,207	–	–	0.69%	26
2019 Q2	$1.3M	Hold	16,207	–	–	0.69%	24
2019 Q1	$1.29M	Hold	16,207	–	–	0.71%	17
2018 Q4	$1.18M	Buy	+16,207	New	+$1.14M	0.57%	12

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Covenant Partners's MRK Position: Q4 2024 in Review

Covenant Partners sold out of Merck (MRK) in Q4 2024, closing a stake of 11,758 shares — an estimated $1.34M sold.

Covenant Partners first reported a position in MRK in Q4 2018 and held it in 24 quarters. The position peaked at $1.52M in Q1 2024. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

Covenant Partners reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
Covenant Partners sold 11,758 Merck shares in Q4 2024, an estimated $1.34M.
Covenant Partners first reported a position in Merck in Q4 2018 and held it in 24 quarters.
Covenant Partners's Merck position peaked at $1.52M in Q1 2024.
3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Covenant Partners's 13F filing for Q4 2024, filed 14 Feb 2025.